Summary

Flumazenil in Emergency Care: Four Decades of an Antidote With Benefits and Limitations

Santiago Nogué-Xarau1,2, Montserrat Amigó-Tadin3, Núria Pi-Sala1,4, Milagros García-Peláez1,5, M. Àngels Gispert-Ametller1,6, Edurne Fernández de Gamarra-Martínez1,7


Affiliation of the authors

1Grupo de Antídotos de la Societat Catalana de Farmàcia Clínica. 2Fundación Española de Toxicología Clínica. 3Grupo de Trabajo de Toxicología de la Societat Catalana de Medicina d’Urgències y Emergències. 4Servicio de Farmacia, Hospital de Figueres, Girona, Spain. 5Servicio de Farmacia, Hospital General de Granollers, Barcelona, Spain. 6Servicio de Urgencias, Hospital Universitario Dr. Josep Trueta, Girona, Spain. 7Servicio de Farmacia, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.

DOI

Quote

Nogué-Xarau S, Amigó-Tadin M, Pi-Sala N, García-Peláez M, Gispert-Ametller MA, Fernández de Gamarra-Martínez E. Flumazenil in Emergency Care: Four Decades of an Antidote With Benefits and Limitations. Rev Esp Urg Emerg. 2026;5:219-25

More articles by the authors

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.